BIOMAT Database Logo BIOMAT Database Logo

Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme). 1997

E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia.

The effect of N(alpha)-carboxyalkylated dipeptides on angiotensin-converting and kinin-degrading activity of angiotensin-converting enzyme (ACE, dipeptidyl carboxypeptidase) was studied. These inhibitors selectively affected ACE-induced hydrolysis of angiotensin I-like and bradykinin-like (hippuryl-His-Leu and hippuryl-Phe-Arg, respectively) substrates in microsomal fractions of rat lungs and kidneys and rat blood serum. The inhibition constants of both types of activity were determined for these enzyme preparations and also for ACE from porcine seminal fluid and highly purified ACE from porcine lung. In all cases high inhibition selectivity of angiotensin-generating and kininase activities of ACE was found.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Angiotensin-converting enzyme, dipeptidyl carboxypeptidase I, and its inhibitors.
January 1988, Methods in enzymology,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Fluorimetric determination of dipeptidyl carboxypeptidase. (angiotensin-I-converting enzyme).
January 1975, Enzyme,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
August 1999, Biochemistry. Biokhimiia,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Peptide inhibitors of pulmonary angiotensin I converting enzyme.
September 1971, Biochimica et biophysica acta,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
January 1990, Journal of cardiovascular pharmacology,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Novel Umami Peptide IPIPATKT with Dual Dipeptidyl Peptidase-IV and Angiotensin I-Converting Enzyme Inhibitory Activities.
May 2021, Journal of agricultural and food chemistry,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Angiotensin-converting enzyme and a second dipeptidyl carboxypeptidase from hog plasma.
July 1972, Biochimica et biophysica acta,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Purification and characterization of a dipeptidyl carboxypeptidase from the polychaete Neanthes virens resembling angiotensin I converting enzyme.
May 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Localization of angiotensin converting enzyme (dipeptidyl carboxypeptidase) in swine sperm by immunofluorescence.
September 1984, Life sciences,
E V Kalinina, and V F Posdnev, and N V Komissarova, and O A Gomazkov
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme.
November 2000, The British journal of nutrition,
Copied contents to your clipboard!